Metro-Minnesota NCI Community Oncology Research Program

Minneapolis, Minnesota 55416

0 studies enrolling now · 1 studies all time

What they study most

Estrogen Receptor Positive Breast Cancer, HER-2 Positive Breast Cancer

Studies at this site

• Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer — Running, not enrolling